Funded Startups in Raleigh
Among the 50 most recent funded entries listed for Raleigh, the largest disclosed round is Slate Medicines’ $130M (Series A) on 2026-02-24, which dwarfs th…
Among the 50 most recent funded entries listed for Raleigh, the largest disclosed round is Slate Medicines’ $130M (Series A) on 2026-02-24, which dwarfs the next-largest disclosed amount of $175M (Element451) at 2024-12-06; after those two, the disclosed figures cluster mostly below $40M (e.g., Opus Genetics $35M on 2026-04-06; Relay $35M on 2024-06-10). Outliers also show up on the low end: the smallest disclosed amount is $20K (QuantmRE, Seed) on 2024-06-26, compared with multiple mid-six-figure to single-digit millions (e.g., North Carolina Independent Colleges and Universities $80K on 2026-04-27; HopeLine $40K on 2024-10-10). Timing is concentrated: many rounds fall in late 2024 through mid-2026, and the newest entry in the table is Green Bridge (undisclosed) on 2026-06-22. Stage/label usage is heavy with missing disclosed amounts and unclear round types: 13 entries are “undisclosed” by amount, and 43 entries are “Series Unknown”/unlabeled stage variants (including “Venture - Series Unknown”). Sector-wise, Biotechnology appears repeatedly (e.g., Uniform Bio $2M on 2026-06-02; Inceptor Bio $21M on 2025-02-25; Pathalys Pharma $105M on 2024-08-20).
Most recent rounds
50 of 11363 more funded startups
This page shows the 50 most recent rounds (back to Jan 2024). The full 113-company history for this listing is available on a paid plan.
Unlock all 113 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
What stands out in disclosed round size for Raleigh, and how extreme is the spread?
The disclosed ceiling is Element451’s $175M (2024-12-06), with Slate Medicines also far above the pack at $130M (2026-02-24); the smallest disclosed amount is QuantmRE’s $20K (2024-06-26). Between those edges, many disclosed rounds sit in the tens of thousands to low tens of millions range (e.g., HopeLine $40K on 2024-10-10; Relay $35M on 2024-06-10; ReFiBuy $15M on 2026-05-05).
Do the most recent rounds cluster in time, or are they evenly spread across the window?
The table spans 2024-01-11 (Pryon, $80K) through 2026-06-22 (Green Bridge, undisclosed), and the densest visible activity is in late 2024 through 2026 (e.g., a cluster in 2026-06-02 with AdVenture Development $74M and Uniform Bio $2M). Several 2024 entries also appear concentrated around August 2024 (Allstacks $10M on 2024-08-20; Pathalys Pharma $105M on 2024-08-20; De Novo Foodlabs $2M on 2024-08-19).
How dominant are missing or unclear deal details (amounts and round types)?
Disclosed amounts are missing for 13 entries marked “undisclosed” (e.g., Green Bridge on 2026-06-22; Intelligent Locations on 2025-10-14; DG Matrix on 2024-02-20). Round type is also frequently unclear: 43 of 50 entries are labeled “Series Unknown” or close variants (including “Venture - Series Unknown” and a blank stage for Murphy's Naturals on 2024-03-13).
Are any sectors over-represented compared with others in this Raleigh list?
Biotechnology appears in multiple rows across different years, including Uniform Bio ($2M on 2026-06-02), Opus Genetics ($35M on 2026-04-06), Inceptor Bio ($21M on 2025-02-25), and Pathalys Pharma ($105M on 2024-08-20). Other sectors show up as one-off or low-frequency entries (e.g., Hardware with only Relay $35M on 2024-06-10; Manufacturing with Voxel Innovations $4M on 2024-05-14).
Which entries look like size outliers worth researching further?
Beyond the two large disclosed rounds (Element451 $175M on 2024-12-06 and Slate Medicines $130M on 2026-02-24), the list also contains major single-entry steps relative to nearby deals, such as Pathalys Pharma’s $105M (2024-08-20). At the low end, QuantmRE’s $20K (2024-06-26) and EGC’s $50K (2024-04-23) contrast with mid-sized deals nearby (e.g., Offline $1M on 2024-05-03; Swab-Bot $300K on 2025-09-12).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.